GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones. (Q39336234)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

F L Campos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroendocrinology

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1386-1397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

Are men at greater risk for Parkinson's disease than women?

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Estradiol stimulates GDNF expression in developing hypothalamic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Dietary supplementation of soy germ phytoestrogens or estradiol improves spatial memory performance and increases gene expression of BDNF, TrkB receptor and synaptic factors in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Involvement of Brain‐Derived Neurotrophic Factor and Neurogenesis in Oestradiol Neuroprotection of the Hippocampus of Hypertensive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Estrogen-inducible, sex-specific expression of brain-derived neurotrophic factor mRNA in a forebrain song control nucleus of the juvenile zebra finch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Estrogen stimulates brain-derived neurotrophic factor expression in embryonic mouse midbrain neurons through a membrane-mediated and calcium-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Estradiol, insulin-like growth factor-I and brain aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERalpha in primary cultures of mouse mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Neuroprotective actions of sex steroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Postmenopausal estrogen use affects risk for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Risk of Parkinson's disease among first-degree relatives: A community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Parkinsonism death rates by race, sex, and geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Neuroprotection by estradiol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

17beta-estradiol rescues spinal motoneurons from AMPA-induced toxicity: a role for glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Immunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Unconventional effects of estrogen uncovered

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Ability of GDNF to diminish free radical production leads to protection against kainate-induced excitotoxicity in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

GDNF modulates HO-1 expression in substantia nigra postnatal cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

Driving GDNF expression: the green and the red traffic lights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02348.X

10.1111/J.1365-2826.2012.02348.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672424%20AND%20SRC:MED&resulttype=core&format=json